White matter changes in Alzheimer's disease: contributor, consequence or co-pathology? - Summary - MDSpire

White matter changes in Alzheimer's disease: contributor, consequence or co-pathology?

  • By

  • Julia Neitzel

  • October 30, 2025

  • 0 min

Share

Objective:

To explore the relationship between white matter changes and Alzheimer's disease (AD) pathology, particularly focusing on the role of tau deposition in influencing white matter integrity.

Key Findings:
  • Cortical tau deposition is associated with lower baseline volume of connected white matter regions and accelerated white matter volume loss over time.
  • Lower white matter volume does not predict faster tau accumulation in adjacent cortical regions, indicating a one-way relationship.
  • Faster tau accumulation correlates with faster degeneration of connected white matter regions, suggesting a potential causal link.
Interpretation:

The findings suggest that white matter changes are a downstream consequence of AD pathology, with tau aggregation potentially leading to white matter degeneration, highlighting the need for further investigation into this relationship.

Limitations:
  • The study's directionality may reflect measurement sensitivity rather than true causality, which could misinterpret the relationship.
  • MRI-derived volume loss may miss early white matter alterations, limiting the understanding of initial changes.
  • The analysis used an atlas from healthy participants, potentially overlooking individual differences that could affect results.
  • Only macroscopic changes were examined, ignoring the potential impact of microscopic white matter pathology on the findings.
Conclusion:

The study supports the idea that tau-mediated white matter damage may precede clinical symptoms in AD, emphasizing the need for further research into the mechanisms linking tau pathology and white matter integrity.

Original Source(s)

Related Content